Engineering

We are doggedly determined, and valued not only for winning difficult cases but also for advising on when to save a fight for another day

Engineering

The breadth and depth of experience in the team is unrivalled

We represent some of the world’s leading companies in a variety of engineering fields, ranging from surgical devices to lasers, from contact lenses to window hinges and from aircraft wings to drug delivery systems. Our clients include Johnson & Johnson, Mars and Raytheon, as well as many other household names and SMEs.

Our approach is to recruit the best technical specialists and then embed them with our clients’ in-house technology teams. This way we can direct prosecution in the most effective manner and provide comprehensive advice on strategies for maximising value from the resulting IP. We are determined hunters when it comes to obtaining patents and are valued not only for winning difficult cases, but also for advising on when to save a fight for another day.

When it comes to resolving disputes, our approach is one of level-headed perseverance, with an awareness on the realities of what can be achieved within the constraints of available resources and the commercial sensitivities prevalent across the engineering sector.

Our patent specialists work hand-in-hand with our trade mark and transactions teams in order to provide a complete IP service to our clients.


“On the engineering and technology side, the firm continues to expand its AI and machine learning practice, for example for clients in the fintech sector, while growing its medical device work, with a strong opposition and appeals practice.”

Legal 500 2020


 

10
Partners
13
Senior Associates
12
Associates
8
Technical Assistants

Ethicon Endo-Surgery v Covidien LLP

In EPO opposition proceedings, we represent Ethicon Endo-Surgery in a multi-patent dispute with Covidien LLP. We have successfully defended and attacked scores of patents involving surgical stapler technology. The depth of medical device knowledge and familiarity with the prior art in this space has enabled our team to lead with a winning strategy for Europe.